Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -0.17% is 101% below its 5-year average of 25.04%, near the low end of its 5-year range (-0.17%–27.59%).
As of the fiscal period ended Tuesday, June 30, 2026. 101.36% below its 12-month average of 12.33%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -0.17%.
RETURN ON EQUITY (ROE)
-0.17%
RETURN ON EQUITY (ROE) AVG TTM
12.33%
RETURN ON EQUITY (ROE) AVG 3Y
24.41%
RETURN ON EQUITY (ROE) AVG 5Y
25.04%
RETURN ON EQUITY (ROE) AVG 10Y
23.24%
RETURN ON EQUITY (ROE) AVG 15Y
15.44%
RETURN ON EQUITY (ROE) AVG 20Y
15.05%
CURRENT VS TTM AVG
-101.36%
CURRENT VS 3Y AVG
-100.69%
CURRENT VS 5Y AVG
-100.67%
CURRENT VS 10Y AVG
-100.72%
CURRENT VS 15Y AVG
-101.09%
CURRENT VS 20Y AVG
-101.11%
SECTOR MEDIAN · HEALTHCARE
13.01%
median of 84 covered companies
CURRENT VS SECTOR MEDIAN
-101.29%
vs the sector median at left
Molina Healthcare, Inc.
Market Cap
$9.92B
Return on Equity (ROE)
-0.17%
TTM Avg
12.33%
3Y Avg
24.41%
5Y Avg
25.04%
Market Cap
$9.95B
Return on Equity (ROE)
11.23%
TTM Avg
7.12%
3Y Avg
6.90%
5Y Avg
7.16%
Market Cap
$9.70B
Return on Equity (ROE)
12.77%
TTM Avg
11.88%
3Y Avg
12.69%
5Y Avg
13.50%
Market Cap
$10.27B
Return on Equity (ROE)
15.51%
TTM Avg
15.81%
3Y Avg
15.92%
5Y Avg
17.27%
Market Cap
$10.31B
Return on Equity (ROE)
3.10%
TTM Avg
-8.94%
3Y Avg
-15.72%
5Y Avg
1.14%
Market Cap
$9.36B
Return on Equity (ROE)
26.39%
TTM Avg
25.41%
3Y Avg
19.99%
5Y Avg
14.02%
Market Cap
$10.56B
Return on Equity (ROE)
9.77%
TTM Avg
10.54%
3Y Avg
10.84%
5Y Avg
19.93%
Market Cap
$10.89B
Return on Equity (ROE)
6.85%
TTM Avg
4.70%
3Y Avg
4.67%
5Y Avg
11.22%
Market Cap
$11.17B
Return on Equity (ROE)
20.31%
TTM Avg
18.80%
3Y Avg
15.17%
5Y Avg
15.31%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Molina Healthcare, Inc. (MOH) | $9.92B | -0.17% | 12.33% | 24.41% | 25.04% |
| Globus Medical, Inc. (GMED)vs › | $9.95B | 11.23% | 7.12% | 6.90% | 7.16% |
| Henry Schein, Inc. (HSIC)vs › | $9.70B | 12.77% | 11.88% | 12.69% | 13.50% |
| The Ensign Group, Inc. (ENSG)vs › | $10.27B | 15.51% | 15.81% | 15.92% | 17.27% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $10.31B | 3.10% | -8.94% | -15.72% | 1.14% |
| Insulet Corp. (PODD)vs › | $9.36B | 26.39% | 25.41% | 19.99% | 14.02% |
| Align Technology, Inc. (ALGN)vs › | $10.56B | 9.77% | 10.54% | 10.84% | 19.93% |
| The Cooper Companies, Inc. (COO)vs › | $10.89B | 6.85% | 4.70% | 4.67% | 11.22% |
| Universal Health Services, Inc. (UHS)vs › | $11.17B | 20.31% | 18.80% | 15.17% | 15.31% |
| Bio-Techne Corporation (TECH)vs › | $11.36B | 8.63% | 6.23% | 8.78% | 10.01% |
ROE
-0.2%
ROA
-0.0%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -0.17% |
| 2026-03-31 | 4.61% |
| 2025-12-31 | 11.60% |
| 2025-09-30 | 21.07% |
| 2025-06-30 | 24.55% |
| 2025-03-31 | 27.29% |
| 2024-12-31 | 26.22% |
| 2024-09-30 | 23.98% |
| 2024-06-30 | 21.95% |
| 2024-03-31 | 23.84% |
| 2023-12-31 | 25.88% |
| 2023-09-30 | 24.00% |
| 2023-06-30 | 25.30% |
| 2023-03-31 | 26.00% |
| 2022-12-31 | 26.72% |
| 2022-09-30 | 27.59% |
| 2022-06-30 | 26.57% |
| 2022-03-31 | 24.66% |
| 2021-12-31 | 25.06% |
| 2021-09-30 | 23.43% |
| 2021-06-30 | 26.67% |
| 2021-03-31 | 33.41% |
| 2020-12-31 | 32.11% |
| 2020-09-30 | 36.67% |
| 2020-06-30 | 39.93% |
| 2020-03-31 | 43.53% |
| 2019-12-31 | 37.60% |
| 2019-09-30 | 42.05% |
| 2019-06-30 | 45.62% |
| 2019-03-31 | 43.49% |
| 2018-12-31 | 42.93% |
| 2018-09-30 | 15.63% |
| 2018-06-30 | -3.02% |
| 2018-03-31 | -31.04% |
| 2017-12-31 | -38.29% |
| 2017-09-30 | -23.86% |
| 2017-06-30 | -13.28% |
| 2017-03-31 | 3.53% |
| 2016-12-31 | 0.49% |
| 2016-09-30 | 7.61% |
| 2016-06-30 | 8.08% |
| 2016-03-31 | 8.72% |
| 2015-12-31 | 9.16% |
| 2015-09-30 | 9.67% |
| 2015-06-30 | 7.99% |
| 2015-03-31 | 8.23% |
| 2014-12-31 | 6.16% |
| 2014-09-30 | 2.00% |
| 2014-06-30 | 1.17% |
| 2014-03-31 | 3.06% |
| 2013-12-31 | 5.93% |
| 2013-09-30 | 9.82% |
| 2013-06-30 | 9.53% |
| 2013-03-31 | 2.83% |
| 2012-12-31 | 1.25% |
| 2012-09-30 | -6.47% |
| 2012-06-30 | -4.45% |
| 2012-03-31 | 2.78% |
| 2011-12-31 | 2.76% |
| 2011-09-30 | 9.13% |
| 2011-06-30 | 8.96% |
| 2011-03-31 | 8.34% |
| 2010-12-31 | 7.64% |
| 2010-09-30 | 4.71% |
| 2010-06-30 | 4.45% |
| 2010-03-31 | 5.28% |
| 2009-12-31 | 5.69% |
| 2009-09-30 | 9.34% |
| 2009-06-30 | 11.01% |
| 2009-03-31 | 11.36% |
| 2008-12-31 | 11.34% |
| 2008-09-30 | 12.34% |
| 2008-06-30 | 12.94% |
| 2008-03-31 | 12.17% |
| 2007-12-31 | 11.89% |
| 2007-09-30 | 11.11% |
| 2007-06-30 | 10.45% |
| 2007-03-31 | 10.81% |
| 2006-12-31 | 10.88% |
| 2006-09-30 | 11.02% |
| 2006-06-30 | 10.03% |
| 2006-03-31 | 5.70% |
| 2005-12-31 | 7.61% |
| 2005-09-30 | 9.44% |
| 2005-06-30 | 12.43% |
| 2005-03-31 | 17.14% |
| 2004-12-31 | 16.87% |
| 2004-09-30 | 16.43% |
| 2004-06-30 | 15.82% |
| 2004-03-31 | 16.18% |
| 2003-12-31 | 19.21% |
